These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24407917)

  • 1. Response to Giannelli et al.--comments on potential efficacy of monthly administrations of spot-on moxidectin 2.5%/imidacloprid 10% in the simultaneous prevention of major canine filarioses.
    Traversa D; Famigli Bergamini P; Fracassi F; Pampurini F; Boari A
    Parasitol Res; 2014 Mar; 113(3):1091-2. PubMed ID: 24407917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comments on potential efficacy of monthly administrations of spot-on moxidectin 2.5%/imidacloprid 10% in the simultaneous prevention of major canine filarioses.
    Giannelli A; Daugschies A; Dantas-Torres F; Otranto D
    Parasitol Res; 2013 Nov; 112(11):3979-80. PubMed ID: 24096604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential efficacy of monthly administrations of spot-on moxidectin 2.5%/imidacloprid 10% in the simultaneous prevention of major canine filarioses.
    Traversa D; Mazzi A; Di Cesare A; Famigli Bergamini P; Fracassi F; Fanini G; Aste G; Pampurini F; Boari A
    Parasitol Res; 2013 Nov; 112(11):3753-6. PubMed ID: 23925446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the Persistent Preventive Efficacy of 2.5 % Moxidectin/10 % Imidacloprid Spot-on (Advocate®, Advantage® Multi) in Dogs Experimentally Infected with Angiostrongylus vasorum.
    Böhm C; Petry G; Schmidt H; Raue K; Barthel F; Schaper R
    Parasitol Res; 2017 Aug; 116(Suppl 1):1-10. PubMed ID: 28717944
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of the Efficacy and Safety of an Imidacloprid 10 % / Moxidectin 1 % Spot-on Formulation (Advocate
    Di Cesare A; Veronesi F; Capelli G; Deuster K; Schaper R; Basano FS; Nazzari R; Paoletti B; Traversa D
    Parasitol Res; 2017 Aug; 116(Suppl 1):55-64. PubMed ID: 28717948
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the Clinical Efficacy and Safety of a Spot-on Combination of Imidacloprid 10 % / Moxidectin 2.5 % (Advocate
    Veronesi F; Di Cesare A; Braun G; Günther L; Morganti G; Rueca F; Petry G; Schaper R; Traversa D
    Parasitol Res; 2017 Aug; 116(Suppl 1):65-74. PubMed ID: 28717949
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the Adulticidal Efficacy of Imidacloprid 10 %/Moxidectin 2.5 % (w/v) Spot-on (Advocate®, Advantage® Multi) against Dirofilaria repens in Experimentally Infected Dogs.
    Petry G; Genchi M; Schmidt H; Schaper R; Lawrenz B; Genchi C
    Parasitol Res; 2015 Aug; 114 Suppl 1():S131-44. PubMed ID: 26152414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monthly application of 10 per cent moxidectin and 2.5 per cent imidacloprid spot-on to prevent relapses in generalised demodicosis: a pilot study.
    Colombo S; Leone F; Vercelli A; Cornegliani L
    Vet Rec; 2012 Sep; 171(11):272. PubMed ID: 22791522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of dog thelaziosis caused by Thelazia callipaeda (Spirurida, Thelaziidae) using a topical formulation of imidacloprid 10% and moxidectin 2.5%.
    Bianciardi P; Otranto D
    Vet Parasitol; 2005 Apr; 129(1-2):89-93. PubMed ID: 15817208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imidacloprid plus moxidectin topical solution for the prevention of heartworm disease (Dirofiloria immitis) in dogs.
    Arther RG; Bowman DD; Slone RL; Travis LE
    Parasitol Res; 2005 Oct; 97 Suppl 1():S76-S80. PubMed ID: 16228279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of moxidectin 2.5% and imidacloprid 10% in the treatment of ocular thelaziosis by Thelazia callipaeda in naturally infected dogs.
    Otranto D; Colella V; Crescenzo G; Solari Basano F; Nazzari R; Capelli G; Petry G; Schaper R; Pollmeier M; Mallia E; Dantas-Torres F; Lia RP
    Vet Parasitol; 2016 Aug; 227():118-21. PubMed ID: 27523947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of canine generalized demodicosis associated with hyperadrenocorticism with spot-on moxidectin and imidacloprid.
    Huang HP; Lien YH
    Acta Vet Scand; 2013 May; 55(1):40. PubMed ID: 23663380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot trial evaluating the efficacy of a 10% imidacloprid/2.5% moxidectin spot-on formulation in the treatment of natural nasal capillariosis in dogs.
    Veronesi F; Morganti G; Di Cesare A; Schaper R; Traversa D
    Vet Parasitol; 2014 Feb; 200(1-2):133-8. PubMed ID: 24365240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study.
    Krieger K; Heine J; Dumont P; Hellmann K
    Parasitol Res; 2005 Oct; 97 Suppl 1():S81-S88. PubMed ID: 16228280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of imidacloprid 10 per cent/moxidectin 2-5 per cent spot-on in the treatment of cheyletiellosis in dogs.
    Loft KE; Willesen JL
    Vet Rec; 2007 Apr; 160(15):528-9. PubMed ID: 17435103
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical evaluation of the safety and efficacy of 10% imidacloprid + 2.5% moxidectin topical solution for the treatment of ear mite (Otodectes cynotis) infestations in dogs.
    Arther RG; Davis WL; Jacobsen JA; Lewis VA; Settje TL
    Vet Parasitol; 2015 May; 210(1-2):64-8. PubMed ID: 25801226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the efficacy of a combination of imidacloprid and moxidectin against immature Toxocara catiin cats.
    Reinemeyer CR; Charles S
    Parasitol Res; 2003 Jul; 90 Suppl 3():S140-1. PubMed ID: 12928882
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of a spot-on formulation containing moxidectin 2.5%/imidacloprid 10% for the treatment of Cercopithifilaria spp. and Onchocerca lupi microfilariae in naturally infected dogs from Portugal.
    Otranto D; Colella V; Bezerra-Santos MA; Mendoza-Roldan JA; Cavalera MA; Pereira A; Schaper R; Maia C
    Parasit Vectors; 2021 Apr; 14(1):199. PubMed ID: 33849643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine generalized demodicosis treated with varying doses of a 2.5% moxidectin+10% imidacloprid spot-on and oral ivermectin: parasiticidal effects and long-term treatment outcomes.
    Paterson TE; Halliwell RE; Fields PJ; Louw ML; Ball G; Louw J; Pinckney R
    Vet Parasitol; 2014 Oct; 205(3-4):687-96. PubMed ID: 25262617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of imidacloprid/moxidectin spot-on solution and fenbendazole in the treatment of dogs naturally infected with Angiostrongylus vasorum (Baillet, 1866).
    Willesen JL; Kristensen AT; Jensen AL; Heine J; Koch J
    Vet Parasitol; 2007 Jul; 147(3-4):258-64. PubMed ID: 17544583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.